Tag: CBT > Department of Health and Human Services: Page 2

Cannabis Rescheduling

Is Cannabis in Schedule I or V? HHS Secretary Forgets

U.S. Health Secretary Xavier Becerra couldn’t remember the plant’s classification during a subcommittee hearing on his department’s budget request, during which a dispute over HHS’ rescheduling recommendation arose.

March 20, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

Top Stories

Lawmakers 'Deeply Concerned' About Medical Cannabis Act's Implementation

Congressmen Earl Blumenauer and Andy Harris sent a letter requesting answers from the DEA and HHS on barriers to cannabis research and the government agencies’ missed report deadline that is required by the Medical Marijuana and Cannabidiol Research Expansion Act.

March 12, 2024

Regulations and Reform

DOJ Declines to Address Media Inquiry on Cannabis Rescheduling, Points to 2020 Resource Guide

A Department of Justice spokesperson said the government has nothing further to provide beyond its confirmation of review.

February 27, 2024

Cannabis Rescheduling

Former Police Chiefs, Prosecutors, Correctional Officials Urge Biden to Reschedule Cannabis

Officials who dedicated their careers to protecting public safety and reducing unnecessary arrests say cannabis prohibition has become problematic.

February 22, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Legislation and Regulation

Gillibrand, Nadler Joined by New York Leaders in Calling DEA to Deschedule Cannabis

Seven New York Democrats from all elected levels united with NORML, business leaders and advocates in Harlem to push for full removal.

January 29, 2024

Interviews & Opinion

7 Takeaways From the Feds' Cannabis Rescheduling Recommendation

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

January 24, 2024

Cannabis Rescheduling

DOJ Official Says HHS Will Release Unredacted Cannabis Rescheduling Recommendation Letter

Attorney Matthew Zorn announced that, in response to his FOIA lawsuit, an official confirmed the Department of Health & Human Services would release “the letter and its enclosures in their entirety.”

January 11, 2024